Kerry Gilmore

Title: Kerry Gilmore: Innovator in DNA Cleavage Technology

Introduction

Kerry Gilmore is a prominent inventor based in Tallahassee, Florida. She has made significant contributions to the field of biochemistry, particularly in the development of innovative reagents for DNA cleavage. Her work focuses on enhancing the efficacy of cancer treatments through novel chemical compounds.

Latest Patents

Kerry Gilmore holds a patent for "C-lysine conjugates as pH-controlled, light-activated reagents for double stranded DNA cleavage and associated methods." This patent describes compounds and methods that utilize light-activated lysine conjugates to achieve double-stranded DNA cleavage. The technology is particularly effective at slightly acidic pH levels, which are suitable for selectively targeting cancer cells. The presence of two amino groups with different basicities enhances the solubility and affinity of these compounds to DNA. The protonation of the second amino group at the desired pH threshold leads to increased DNA-cleaving ability, making these molecules promising candidates for phototherapy in cancer treatment.

Career Highlights

Kerry Gilmore is affiliated with the Florida State University Research Foundation, Inc., where she continues her research and development efforts. Her innovative approach to DNA cleavage has garnered attention in the scientific community, and her work is paving the way for advancements in cancer therapies.

Collaborations

Kerry has collaborated with notable researchers such as Igor Alabugin and Serguei V Kovalenko. These partnerships have contributed to the depth and breadth of her research, enhancing the impact of her inventions.

Conclusion

Kerry Gilmore's contributions to the field of biochemistry, particularly in the area of DNA cleavage technology, highlight her role as an influential inventor. Her innovative work has the potential to significantly advance cancer treatment methodologies.